Quantify

Biogen Inc. vs Johnson & Johnson — Stock Comparison

Biogen Inc. (BIIB) and Johnson & Johnson (JNJ) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.

vs
Q·Score Winner
Biogen Inc.
BIIB7.5/10vs 7.1/10

Biogen Inc. narrowly edges Johnson & Johnson on Q·Score (7.5 vs 7.1 out of 10), led by Health (9.7 vs 6.5) and Growth (7.8 vs 5.1). Johnson & Johnson scores higher on Quality, reflecting stronger profitability and returns. Analyst consensus targets imply greater upside for BIIB (+10.8%) than for JNJ (+7.3%).

Price Performance

Normalised to 100 at period start — shows relative performance.

Loading…
● BIIB● JNJ

Q·Score Breakdown

7.5
Bullish
Overall
7.1
Bullish
7
Quality
9.3
9.7
Health
6.5
7.8
Growth
5.1
6.4
Valuation
7
6.7
Sentiment
6.9
BIIB

Clean balance sheet with low leverage (0.4× debt-to-equity).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

⚠ earnings contracting 53% year-over-year.

Analyst Consensus

Bullish
+10.8%
Target $220.13
30 analysts
Bullish
+7.3%
Target $252.87
23 analysts

Fundamentals

BIIB
JNJ
21.4×
Trailing P/E
27.3×
11.9×
Forward P/E
18.5×
13.80%
Profit Margin
21.83%
78.72%
Gross Margin
68.04%
7.70%
ROE
26.42%
1.90%
Revenue Growth
9.90%
31.10%
Earnings Growth
-52.90%
0.18
Beta
0.26
—
Dividend Yield
2.27%
$29.3B
Market Cap
$567.3B
52-Week Range
BIIB
$12191% of range$206
JNJ
$14984% of range$252

Frequently Asked Questions

BIIB vs JNJ: which stock scores better overall?

Based on Q·Score, Biogen Inc. (BIIB) scores 7.5/10 versus Johnson & Johnson (JNJ) at 7.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.

Which has better revenue growth: BIIB or JNJ?

Biogen Inc. (BIIB) scores higher on Growth (7.8/10 vs 5.1/10). Biogen Inc. reports revenue growth (1.9% YoY) while Johnson & Johnson reports (9.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Is BIIB or JNJ more attractively valued?

Johnson & Johnson (JNJ) scores higher on Valuation (7/10 vs 6.4/10). BIIB trades at 11.9× P/E versus JNJ at 18.5×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

What do analysts say about BIIB vs JNJ?

There are 30 analysts covering BIIB with a consensus price target of $220.13, and 23 analysts covering JNJ with a consensus target of $252.87. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Which is more profitable: BIIB or JNJ?

Johnson & Johnson (JNJ) scores higher on Quality (9.3/10 vs 7/10). Net profit margin: BIIB at 13.8%, JNJ at 21.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Which has stronger financial health: BIIB or JNJ?

Biogen Inc. (BIIB) scores higher on Financial Health (9.7/10 vs 6.5/10). Market beta: BIIB at 0.18, JNJ at 0.26. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

What are the market caps of BIIB and JNJ?

Biogen Inc. (BIIB) has a market capitalisation of $29.3B, while Johnson & Johnson (JNJ) has a market cap of $567.3B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Do BIIB or JNJ pay dividends?

BIIB does not currently pay a dividend, while JNJ pays a dividend yield of 2.27%. Dividend yields fluctuate with share price and company payout decisions.

Related Comparisons

JNJ vs PFEABBV vs JNJBIIB vs VRTXBIIB vs REGNJNJ vs MRKAAPL vs JNJ

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →

Data provided by Yahoo Finance ·  Updated on each page load ·  For informational purposes only · Not financial advice · Quantify.biz © 2026